会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Recombinant HIV and modified packaging cells and method for treating
acquired immune deficiency syndrome
    • 重组HIV和改良包装细胞及治疗获得性免疫缺陷综合征的方法
    • US5753490A
    • 1998-05-19
    • US563597
    • 1995-11-28
    • Syed Zaki SalahuddinNickolas Chelyapov
    • Syed Zaki SalahuddinNickolas Chelyapov
    • C12N7/00C12N15/867C12N7/01C12N7/02C12N7/04
    • C12N15/86C12N7/00C12N2740/16021C12N2740/16043
    • A recombinant human immunodeficiency virus (rHIV) and recombinant mammalian cell-line (packaging systems) and a method for treating infection of cells by human immuneodeficiency virus HIV. rHIV, such as rHIV-1, comprises of a gene construction which includes a foreign gene. The expression of this gene is activated in human cells in the presence of wild-type HIV. This gene product can cause cell death in the presence of an appropriate drug, e.g. Acyclovir. This gene product is typically a viral thymidine kinase. rHIV is so constructed that it is unable to replicate by itself due to the absence of a regulatory gene that is necessary for its replication, such as tat or rev or both. The recombinant mammalian cell-line packaging system comprises in its genome a recombinant gene construction which typically includes a functional regulatory gene from HIV which is missing from rHIV, such as the tat or rev genes or both. The method for treating infection of cells by HIV comprises administering a composition comprising rHIV, which is produced in vitro from a recombinant mammalian cell-line, and treating with a nucleoside analog, such as Acyclovir or Gancyclovir.
    • 重组人类免疫缺陷病毒(rHIV)和重组哺乳动物细胞系(包装系统)以及人免疫缺陷病毒HIV感染细胞的方法。 rHIV,如rHIV-1,由包含外来基因的基因构建构成。 在野生型HIV存在下,该基因的表达在人细胞中被激活。 该基因产物可以在合适的药物存在下引起细胞死亡,例如, 阿昔洛韦 该基因产物通常是病毒胸苷激酶。 由于缺乏对其复制所必需的调节基因,例如tat或rev或两者,rHIV是如此构建,使得它不能自己复制。 重组哺乳动物细胞系包装系统在其基因组中包含重组基因构建体,其通常包含来自HIV的功能调节基因,其从rHIV缺失,例如tat或rev基因或两者。 用于治疗HIV感染细胞的方法包括施用包含rHIV的组合物,所述组合物在体外从重组哺乳动物细胞系产生,并用核苷类似物如阿昔洛韦或Gancyclovir进行治疗。
    • 2. 发明授权
    • Recombinant HIV and modified packaging cells and method for using
    • 重组HIV和改良包装细胞及其使用方法
    • US6063374A
    • 2000-05-16
    • US563360
    • 1995-11-28
    • Syed Zaki SalahuddinNickolas Chelyapov
    • Syed Zaki SalahuddinNickolas Chelyapov
    • C12N7/00C12N15/867A61K48/00C12N15/00C12N15/85
    • C12N15/86C12N7/00C12N2740/16021C12N2740/16043
    • A recombinant human immunodeficiency virus (rHIV) and recombinant mammalian cell-line (packaging systems) and a method for treating infection of cells by human immuneodeficiency virus HIV. rHIV, such as rHIV-1, comprises of a gene construction which includes a foreign gene. The expression of this gene is activated in human cells in the presence of wild-type HIV. This gene product can cause cell death in the presence of an appropriate drug, e.g. Acyclovir. This gene product is typically a viral thymidine kinase. rHIV is so constructed that it is unable to replicate by itself due to the absence of a regulatory gene that is necessary for its replication, such as tat or rev or both. The recombinant mammalian cell-line packaging system comprises in its genome a recombinant gene construction which typically includes a functional regulatory gene from HIV which is missing from rHIV, such as the tat or rev genes or both. The method for treating infection of cells by HIV comprises administering a composition comprising rHIV, which is produced in vitro from a recombinant mammalian cell-line, and treating with a nucleoside analog, such as Acyclovir or Gancyclovir.
    • 重组人类免疫缺陷病毒(rHIV)和重组哺乳动物细胞系(包装系统)以及人免疫缺陷病毒HIV感染细胞的方法。 rHIV,如rHIV-1,由包含外来基因的基因构建构成。 在野生型HIV存在下,该基因的表达在人细胞中被激活。 该基因产物可以在合适的药物存在下引起细胞死亡,例如, 阿昔洛韦 该基因产物通常是病毒胸苷激酶。 由于缺乏对其复制所必需的调节基因,例如tat或rev或两者,rHIV是如此构建,使得它不能自己复制。 重组哺乳动物细胞系包装系统在其基因组中包含重组基因构建体,其通常包含来自HIV的功能调节基因,其从rHIV缺失,例如tat或rev基因或两者。 用于治疗HIV感染细胞的方法包括施用包含rHIV的组合物,所述组合物在体外从重组哺乳动物细胞系产生,并用核苷类似物如阿昔洛韦或Gancyclovir进行治疗。